STAA Stock Analysis: Buy, Sell, or Hold?
STAA - Staar Surgical Co
$23.14
0.07 (0.30%)
▲
5d:
-11.61%
30d:
-4.34%
90d:
-29.43%
WAIT
LOW Confidence
Analysis Updated: Aug 21, 2026 12:00 AM ET
Earnings: Aug 12, 2026
0d
Smart Money Accumulation
Options open interest is building while the stock consolidates - a pattern consistent with institutional accumulation. View Scanner →
Signal fired Aug 17, 2026 at $24.11 · last confirmed Aug 17, 2026
Strength: 3.9/10
Get Alerted When STAA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: STAA is down 11.6% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: STAA is down 11.6% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$49.84
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$30.95
25.2% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: STAA is currently trading at $23.14, which is considered slightly low relative to its 30-day fair value range of $23.33 to $26.89. From a valuation perspective, the stock is trading at a discount (Forward PE: 22.5) compared to its historical average (39.2). Remarkably, the market is currently pricing in an annual earnings decline of 16.8% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, STAA is showing sideways momentum. The price is currently testing key support at $22.98. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 43/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $27.90 (+20.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, STAA is showing sideways momentum. The price is currently testing key support at $22.98. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 43/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $27.90 (+20.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$23.33 -
$26.89
Company Quality Score
43/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
79.5%
Protect Your Profits
Holding STAA? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (43/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 20.9% below Wall St target ($27.90)
- WARNING: Composite score 43/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$23.33 -
$26.89
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$22.98
Resistance Level
$26.25
Current Trend
Sideways
Technical data as of
Aug 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
22.53
Wall Street Target
$27.90
(+20.9%)
Revenue Growth (YoY)
111.0%
Earnings Growth (YoY)
-10.5%
Profit Margin
1.1%
Valuation Discount vs History
-16.8% cheaper
PE vs Historical
22.5 vs 39.2
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-16.8%
(market-implied from PE analysis)
1-Year Target
$20.76
(-10%)
2-Year Target
$18.69
(-19%)
3-Year Target
$16.82
(-27%)
3-Yr Target (if PE normalizes)
(PE: 23→39)
$29.26
(+27%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.5, Growth: 34.3%)
$55.84
(+142%)
Base:
(SPY PE: 20.1, Growth: 34.3%)
$49.74
(+116%)
Bear:
(PE: 17.1, Growth: 34.3%)
$42.28
(+83%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (130x PE), but valuation improves significantly next year (23x PE) as earnings recover.
Forward PE: 129.87 | Forward EPS (Implied): $0.18
Bull Case
$27.94
(+21%)
Analyst growth 15.0%, PE expands to 136.4
Base Case
$23.14
(0%)
Market implied 0.0%, PE stable at 129.9
Bear Case
$17.70
(-24%)
Severe decline -15.0%, PE contracts to 116.9
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 22.5 to 39.2
Stabilization Target:
$40.13
(+74.0%)
PE Expansion Potential:
+74.0%
Share & Embed Analysis
Last updated: August 23, 2026 1:28 AM ET
Data refreshes hourly during market hours. Next update: 2:28 AM
Data refreshes hourly during market hours. Next update: 2:28 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is STAA showing a specific setup today?
Insider Activity (6 Months)
3
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Broadwood Partners, L.P.
BUY
316017 shares
2026-03-13
Broadwood Partners, L.P.
BUY
299432 shares
2026-03-12
Broadwood Partners, L.P.
BUY
54764 shares
2026-03-11
Top Rated Medical Instruments & Supplies Stocks
Top-rated stocks in Medical Instruments & Supplies by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ISRG
Intuitive Surgical Inc |
BUY
33 analysts |
$478 | 46 HOLD |
|
ALC
Alcon AG |
STRONG BUY
27 analysts |
$86 | 37 SELL |
|
WST
West Pharmaceutical Serv… |
STRONG BUY
13 analysts |
$405 | 66 BUY |
|
RGEN
Repligen Corporation |
STRONG BUY
19 analysts |
$186 | 45 HOLD |
|
RMD
ResMed Inc |
BUY
19 analysts |
$247 | 41 HOLD |
Advanced STAA Option Strategies
Professional options setups generated by AI based on today's STAA price and gamma walls.
